Impact of hemodynamic optimization on reducing pulmonary pressures and adverse clinical events in left ventricular assist device recipients with elevated pulmonary vascular resistance

Back

HFA Premium Access

Impact of hemodynamic optimization on reducing pulmonary pressures and adverse clinical events in left ventricular assist device recipients with elevated pulmonary vascular resistance

Session: Chronic heart failure - treatment 6

Topic: Ventricular Assist Devices

Speaker: Professor M. Kim (Seoul, KR)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Professor Min-Seok Kim

Asan Medical Center, Seoul (Korea (Republic of))

0 follower

6 more presentations in this session

Histological profiling, viral analysis, and follow-up of inflammatory cardiomyopathy in adults supported by long-term left ventricular assist device therapy

Speaker: Doctor M. Ruiz Cano (Bad Oeynhausen, DE)

The impact of sodium glucose transporter 2 inhibitors on cardiac remodeling in a large cohort of unselected patients

Speaker: Doctor V. Copeland (Ramat Gan, IL)

Warfarin and aspirin versus warfarin alone in patients with HeartMate 3 left ventricular assist device: a systematic review and meta-analysis.

Speaker: Mr L. Rezende De Freitas (BR)

Impact of an extended infectiological standard operating procedure on the outcome of patients with VAD-associated infections

Speaker: Mr Y. Streef (Berlin, DE)

Clinical and echocardiographic effects of vericiguat therapy in advanced heart failure patinets undergoing LVAD support

Speaker: Associate Professor G. Poglajen (Ljubljana, SI)

Access the full session

Chronic heart failure - treatment 6

Speakers: Professor M. Kim, Doctor M. Ruiz Cano, Doctor V. Copeland, Mr L. Rezende De Freitas, Mr Y. Streef...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources